BS 2081 Jestha 2
Nepal:
New to Australia?
Are you a newbie to Australia. Click here to know more about Studying in Australia, About living here, getting your first job and planning for Permanent residency.
Guide to OZ Jobs/Rooms listingsNews tagged 'covid 19 vaccine'
AstraZeneca’s COVID-19 vaccine candidate begins late-stage US study
Sep 1, 2020
AstraZeneca Plc said on Monday it has begun enrolling adults for a US-funded, 30,000-subject late-stage study of its high profile COVID-19 vaccine candidate. Trial participants will receive either two doses of the experimental vaccine, dubbed AZD1222, four weeks apart, or a placebo, the company said. The trial is being conducted under U.S. governm...
Pakistan gives go-ahead to Phase 3 COVID-19 vaccine trial
Aug 18, 2020
ISLAMABAD: Pakistan’s drug regulator greenlit the country’s first Phase 3 clinical trial for a potential COVID-19 vaccine, which is being developed by China’s CanSino Biologics (CanSino) and Beijing Institute of Biotechnology. The trial is slated to begin next month, according to an official who will coordinate the exercise. Gover...
Mexico needs 200 million COVID-19 vaccine doses; shots could start in April
Aug 16, 2020
MEXICO CITY: Mexico will need up to 200 million coronavirus vaccine doses, according to a senior government official, and inoculation of its 120 million inhabitants could start as early as April if clinical trials and regulatory approvals for pharmaceutical firm AstraZeneca Plc go as planned. In partnership with the governments of Mexico and Argent...
Russian doctors wary of rapidly approved COVID-19 vaccine, survey shows
Aug 14, 2020
MOSCOW: A majority of Russian doctors would not feel comfortable being injected with Russia’s new COVID-19 vaccine due to the lack of sufficient data about it and its super-fast approval, a survey of more than 3,000 medical professionals showed on Friday. Russia has said that the world’s first vaccine for the novel coronavir...
Sinovac launches late-stage trial for potential COVID-19 vaccine in Indonesia
Aug 11, 2020
JAKARTA/BEIJING: China’s Sinovac Biotech Ltd launched on Tuesday a late-stage human trial involving as many as 1,620 patients in Indonesia for a COVID-19 vaccine candidate that it is developing with Indonesian state-owned peer Bio Farma. The candidate, known as CoronaVac and previously PiCoVacc, is among few potential vaccines that h...
Oxford COVID-19 vaccine developer cautious on 2020 roll-out
Jul 21, 2020
LONDON: The University of Oxford’s possible COVID-19 vaccine could be rolled out by the end of the year but there is no certainty, the lead developer of the vaccine said on Tuesday. The experimental vaccine, which has been licensed to AstraZeneca, produced an immune response in early-stage clinical trials, data showed on Monday...
Pfizer, BioNTech’s coronavirus vaccine candidates get FDA’s ‘fast track’ status
Jul 13, 2020
LONDON: Two experimental coronavirus vaccines jointly developed by German biotech firm BioNTech and US pharmaceutical giant Pfizer have received ‘fast track’ designation from the US drug regulator, the companies said on Monday. The candidates, BNT162b1 and BNT162b2, are the most advanced of the at least four vaccines being assesse...
CanSino’s COVID-19 vaccine candidate approved for military use in China
Jun 29, 2020
BEIJING: China’s military has received the greenlight to use a COVID-19 vaccine candidate developed by its research unit and CanSino Biologics after clinical trials proved it was safe and showed some efficacy, the company said on Monday. The Ad5-nCoV is one of China’s eight vaccine candidates approved for human trials at hom...
Britain’s Prince William visits Oxford COVID-19 vaccine developers
Jun 25, 2020
LONDON: Britain’s Prince William on Wednesday visited the Oxford-based scientists who are working to develop a viable vaccine for COVID-19 as well as trial participants who are helping to determine whether or not it works. The vaccine, originally known as ChAdOx1 nCoV-19, was originally developed by scientists at the University of Oxford, an...
Trials with Oxford COVID-19 vaccine start in Brazil
Jun 24, 2020
SAO PAULO: Oxford University this weekend started human clinical trials for a potential coronavirus vaccine in Brazil, sponsor Lemann Foundation said in a statement late on Monday. Trials will count on 2,000 health workers volunteers in Sao Paulo and 1,000 people in Rio de Janeiro. Brazil’s health regulator Anvisa approved human clinical tria...
- Useful Links
- Send Money to Nepal - 100% legal with real time rate
- Non-Resident-Nepalese Association Australia
- Call Nepal - Cheapest rate - Get 100% bonus of deposit amount
- Buy Bitcoin,Altcoins using Australian Dollar. Cryptocurrency
- Invest on Stocks/Shares online, Earn Online by Copying the pros!!
- Get $5 free credit to call Nepal
- Advertise here